Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological therapy of episodic ataxia type 2 with Fampyra and Acemit
2013-000107-17Phase 3Completed
- Sponsor
- LMU Klinikum
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in episodic ataxia type 2 (EA2) and episodic ataxia (EA) comparing Fampyra arm, Acemit arm and Placebo arm (3 arms). Started Apr 2013; status: completed.
02
Drugs
dalfampridineacetazolamide
03
Conditions
episodic ataxia type 2 (EA2)episodic ataxia (EA)
Beyond the preview
Go deeper on 2013-000107-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000107-17.